Response to immunotherapy in a 20-month-old boy with anti-NMDA receptor encephalitis.
Wong-Kisiel
L C
LC
Department of Neurology and Pediatrics, Mayo Clinic Foundation and College of Medicine, Rochester, MN 55905,USA. mack.kenneth@mayo.edu
Ji
T
T
Renaud
D L
DL
Kotagal
S
S
Patterson
M C
MC
Dalmau
J
J
Mack
K J
KJ
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D000927:Anticonvulsants / Q000627:therapeutic use; D001323:Autoantibodies / Q000097:blood; D020274:Autoimmune Diseases of the Nervous System / Q000188:drug therapy* / Q000276:immunology* / Q000503:physiopathology; D001921:Brain / Q000187:drug effects / Q000276:immunology / Q000503:physiopathology; D020820:Dyskinesias / Q000209:etiology; D004660:Encephalitis / Q000188:drug therapy* / Q000276:immunology* / Q000503:physiopathology; D005076:Exanthema / Q000209:etiology; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007167:Immunotherapy / Q000379:methods*; D007223:Infant; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D016194:Receptors, N-Methyl-D-Aspartate / Q000276:immunology*; D000069283:Rituximab; D012640:Seizures / Q000209:etiology; D013035:Spasm / Q000209:etiology; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000927:Anticonvulsants; D001323:Autoantibodies; D016756:Immunoglobulins, Intravenous; D016194:Receptors, N-Methyl-D-Aspartate; D000069283:Rituximab; D008775:Methylprednisolone
Mov Disord. 2008 Jul 15;23(9):1256-61
18442127
Ann Neurol. 2009 Jul;66(1):11-8
19670433
Arch Neurol. 2009 Apr;66(4):458-64
19364930
Neurology. 2008 Feb 26;70(9):728-9
18299525
Neurology. 2008 Dec 2;71(23):1921-3
19047564
Lancet Neurol. 2008 Dec;7(12):1091-8
18851928
J Pediatr Hematol Oncol. 2006 Sep;28(9):585-93
17006265